FDA’s Opioid Efforts Met With Questions From Science Board

Drug Industry Daily
A A
FDA officials detailed their multipronged effort to limit opioid abuse to a skeptical advisory board on Tuesday.

To View This Article:

Login

Subscribe To Drug Industry Daily